Apogee Therapeutics, Inc. · NASDAQ:APGE

Dambkowski Carl sold 5,500 Apogee Therapeutics, Inc. shares (Form 4)

Traded Jun 3, 2026 · Filed Jun 5, 2026

On Jun 3, 2026, Dambkowski Carl (Chief Medical Officer) sold 5,500 Apogee Therapeutics, Inc. shares at US$78.71 for US$433K under a trading plan, leaving 205,648 shares. Filed Jun 5, 2026 (Form 4).

Sold: 5,500 shares
Price: US$78.71
Value: US$433K
Holding after: 205,648 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Medical Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 3, 2026	Common Stock	Option exercise	4,125	US$22.86	211,148	Direct
Jun 3, 2026	Common Stock	Sale	5,500	US$78.71	205,648	Direct

Source

View original at SEC

Related